Antengene (FRA:722) Total Liabilities : €59.90 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Antengene Total Liabilities?

Antengene's Total Liabilities for the quarter that ended in Jun. 2024 was €59.90 Mil.

Antengene's quarterly Total Liabilities increased from Jun. 2023 (€35.49 Mil) to Dec. 2023 (€60.52 Mil) but then declined from Dec. 2023 (€60.52 Mil) to Jun. 2024 (€59.90 Mil).

Antengene's annual Total Liabilities increased from Dec. 2021 (€22.69 Mil) to Dec. 2022 (€58.07 Mil) and increased from Dec. 2022 (€58.07 Mil) to Dec. 2023 (€60.52 Mil).

Antengene Total Liabilities Historical Data

The historical data trend for Antengene's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antengene Total Liabilities Chart

Antengene Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

19.68

22.69

58.07

60.52

64.79

Antengene Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial								58.07	35.49	60.52	59.90	64.79

Antengene Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Antengene's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	24.515	+	(24.884	+	11.117
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	60.52

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	207.872	-	147.356
	=	60.52

Antengene's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	24.892	+	(24.327	+	10.679
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	59.90

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	187.134	-	127.236
	=	59.90

Antengene Total Liabilities Related Terms

Thank you for viewing the detailed overview of Antengene's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Antengene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Antengene Corp Ltd (FRA:722) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

06996:Hong Kong 722:Germany

Address

1065 West Zhongshan Road, Suites 1206-1209, Block B, Zhongshan SOHO Plaza, Changning District, Shanghai, CHN

Website

https://www.antengene.com

Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically it operates in Chinese Mainland, Hong Kong, Macao and Taiwan and Overseas.

Antengene Headlines

No Headlines